Timothy Eugene Sullivan

Chief Financial Officer at Apellis Pharmaceuticals · 9 reported transactions in 1 company · latest trade Jan 22, 2026

Their trades


Apellis PharmaceuticalsAPLS	Sold $223.9K · 10,287 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $57.2K · 2,892 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $85.6K · 3,856 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $280.3K · 10,000 shares	Oct 21, 2025
Apellis PharmaceuticalsAPLS	Sold $278.3K · 10,000 shares	Sep 8, 2025
Apellis PharmaceuticalsAPLS	Sold $911.8K · 32,729 shares	Sep 8, 2025

Jan 22, 2026 · APLS

$223.9K

Jan 20, 2026 · APLS

$57.2K

Jan 13, 2026 · APLS

$85.6K

Oct 21, 2025 · APLS

$280.3K

Sep 8, 2025 · APLS

$278.3K

Sep 8, 2025 · APLS

$911.8K

9 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Apellis Pharmaceuticals · 9 reported transactions in 1 company · latest trade Jan 22, 2026


Apellis PharmaceuticalsAPLS	Sold $223.9K · 10,287 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $57.2K · 2,892 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $85.6K · 3,856 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $280.3K · 10,000 shares	Oct 21, 2025
Apellis PharmaceuticalsAPLS	Sold $278.3K · 10,000 shares	Sep 8, 2025
Apellis PharmaceuticalsAPLS	Sold $911.8K · 32,729 shares	Sep 8, 2025